Nutex Health Inc. (NUTX) Earnings Call Transcripts

Nutex Health Inc.'s Latest Earnings Call - Q1 FY2026

Nutex Health Inc. reported its Q1 2026 earnings with total revenue of $216.5 million, a 2% increase from Q1 2025. Net income rose significantly to $46.8 million from $21.2 million in the previous year. However, adjusted EBITDA decreased by 21% to $57.6 million, attributed to timing differences in IDR expense recognition. The company announced the completion of a $25 million share repurchase program and initiated another $25 million program, signaling confidence in its intrinsic value. Management maintained guidance, emphasizing continued investment in infrastructure and technology to support growth.

Reported metrics

Guidance from management

Management maintained guidance, focusing on continued investment in infrastructure and technology to support growth, with plans to open three additional hospitals in 2026.

What management said

Yes. I mean I think -- it's a great question, Bill. The -- I mean, obviously, when you have the asset on the books at the point you have it on the books, you're going to have the land and the building, and you'll have a mortgage of some kind or whatever cost to potentially finance it. So outside of that, then we'll decide to move on to the REIT concept, and there will be some slight changes there, but the main point ...

Yes. For the ones that are opening this year in '26, those all have been financed externally. You're correct. In 2027, we have roughly 4 to 5 new projects, and I would say half of those were financed externally, and we're still working on 1 or 2 that will be financed by Nutex. Okay. And some of the 2027 projects have been in development for roughly 6 to 12 months now. And so we're getting to a point of starting cons...

What analysts pressed on

Analysts expressed concerns about the modest patient volume growth despite new hospital openings and the impact of arbitration costs on financials. Questions also focused on the potential balance sheet impact of internal hospital development.

Main topics on the call

• Revenue Growth — Revenue increased by 2% to $216.5 million, with hospital division revenue growing 1.8%. Management highlighted a milder flu season as a factor in modest growth. "Total revenue reached $216.5 million, a 2% increase from $...
• Net Income Increase — Net income more than doubled to $46.8 million from $21.2 million in Q1 2025, driven by improved operational efficiencies and strategic initiatives.
• Adjusted EBITDA Decline — Adjusted EBITDA fell 21% to $57.6 million due to timing differences in IDR expense recognition. "Adjusted EBITDA dropped to $57.6 million, down 21% from $72.8 million in the prior period."
• Share Repurchase Program — Nutex completed a $25 million share repurchase program and initiated another, indicating strong confidence in the company's value. "We completed our inaugural $25 million share repurchase program, retiring approximately ...

Read the full Nutex Health Inc. transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 10 Nutex Health Inc. earnings call transcripts on record, spanning August 9, 2024 to August 7, 2026. Based on this history, Nutex Health Inc. reports quarterly. The most recent call on file is dated August 7, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

NUTX

Exchange

NasdaqCM

Country

US

Sector

Health Care

Industry

Health Care Providers and Services

Calls on record

10

First call

August 9, 2024

Most recent

August 7, 2026

Reporting cadence

quarterly